ATEM Capital Fund LP logo

ATEM Capital Fund LP

North America, New York, United States, New York

Description

ATEM Capital Fund LP is a venture capital fund that invests in breakthrough technologies in Life Sciences.

Investor Profile

ATEM Capital Fund LP has made 10 investments, with 2 in the past 12 months and 30% as lead.

Stage Focus

  • Series B (40%)
  • Seed (30%)
  • Series A (20%)
  • Series C (10%)

Country Focus

  • United States (80%)
  • France (20%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Life Science
  • Wellness
  • Machine Learning
  • Therapeutics
  • Artificial Intelligence (Ai)
  • Bioinformatics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ATEM Capital Fund LP frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Credit Agricole Entreprises
Europe, Ile-de-France, France, Montrouge
Co-Investments: 2
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Novo Ventures
Europe, Hovedstaden, Denmark, Bagsværd
Co-Investments: 2
Kurma Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Mass General Brigham Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 2
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2
Leaps by Bayer
Europe, Nordrhein-Westfalen, Germany, Leverkusen
Co-Investments: 2
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 2
Pontifax
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 2

Which angels does ATEM Capital Fund LP often collaborate with?

AZ
North America, California, United States, San Francisco
Shared Deals: 1
RS
North America, California, United States, Menlo Park
Shared Deals: 1
JM
North America, United States
Shared Deals: 1
MA
North America, California, United States, San Francisco
Shared Deals: 1
MD
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by ATEM Capital Fund LP?

PGxAI

Palo Alto, California, United States

Precision medicine platform powered by GenAI and real world evidence.

BiopharmaLife ScienceMedicalPrecision MedicineSoftware
SeedJan 27, 2025
Amount Raised: $1,500,000
YCare

Tampa, Florida, United States

YCare is a turnkey operator of home care delivery for major health systems and payors.

AnalyticsAppsData IntegrationHealth CareHospitalMedicalOutpatient CarePredictive AnalyticsWellness
SeedOct 1, 2024
PGxCare

Palo Alto, California, United States

PGxCare offers an AI capabilities, enabling analysis of pharmacogenetic data ensuring accurate results tailored to individual needs.

Artificial Intelligence (AI)BioinformaticsHealth CareLife ScienceMachine Learning
SeedMar 19, 2024
Amount Raised: $1,500,000
Walden Biosciences

Cambridge, Massachusetts, United States

Walden Biosciences is a biotechnology company focused on transforming the treatment of kidney disease.

BiotechnologyHealth CareLife Science
Series BOct 1, 2023
Deka Biosciences

Germantown, Maryland, United States

Early stage biotechnology company

BiotechnologyHealth Care
Series BSep 28, 2023
Amount Raised: $20,000,000
Amolyt Pharma

Écully, Rhone-Alpes, France

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

BiotechnologyHealth CareMedicalPharmaceuticalWellness
Series CJan 6, 2023
Amount Raised: $138,629,699
Arpeggio Bio

Boulder, Colorado, United States

Arpeggio builds technology to watch and learn how drugs work.

BiotechnologyHealth CareMachine LearningPharmaceuticalTherapeutics
Series ASep 7, 2022
Amount Raised: $17,000,000
Triumvira Immunologics

Austin, Texas, United States

Triumvira Immunologics is an immunotherapy company that develops novel T cell therapies for cancer.

BiotechnologyClinical TrialsHealth Care
Series AMar 17, 2022
Amount Raised: $45,000,000
Amolyt Pharma

Écully, Rhone-Alpes, France

Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.

BiotechnologyHealth CareMedicalPharmaceuticalWellness
Series BSep 16, 2021
Amount Raised: $80,000,000
Iridia

Carlsbad, California, United States

Iridia is a nanotechnology company that specializes in bio-chemistry, molecular biology, and DNA.

Data StorageElectronicsHealth CareSemiconductor
Series BMar 16, 2021
Amount Raised: $24,000,000